A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy

A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy

Jing Qian,1,* Yingying Qian,1,* Jian Wang,1 Bing Gu,2,3 Dong Pei,1 Shaohua He,1 Fang Zhu,1 Oluf Dimitri Røe,4–7 Jin Xu,8 Lianke Liu,1 Yanhong Gu,1 Renhua Guo,1 Yongmei Yin,1 Yongqian Shu,1 Xiaofeng Chen1 1Department of Oncology, The First Affiliated Hospital of Nanjing...

Full description

Bibliographic Details
Main Authors: Qian J, Qian Y, Wang J, Gu B, Pei D, He S, Zhu F, Røe OD, Xu J, Liu L, Gu Y, Guo R, Yin Y, Shu Y, Chen X
Format: Article
Language:English
Published: Dove Medical Press 2016-02-01
Series:Drug Design, Development and Therapy
Subjects:
Gastric carcinoma
Prognostic factor
TNM classification
Paclitaxel
Oxaliplatin.
Online Access:https://www.dovepress.com/a-clinical-prognostic-scoring-system-for-resectable-gastric-cancer-to--peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/a-clinical-prognostic-scoring-system-for-resectable-gastric-cancer-to--peer-reviewed-article-DDDT

Similar Items